Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and alpha-bulnesene

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with alpha-bulnesene in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(alpha-bulnesene)
Trials
(alpha-bulnesene)
Recent Studies (post-2010) (alpha-bulnesene)
9,156187552907

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CC; Hsu, HC; Huang, HY; Tsai, WJ; Tsai, YC; Yang, WC1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and alpha-bulnesene

ArticleYear
Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
    Biochemical and biophysical research communications, 2006, Jul-07, Volume: 345, Issue:3

    Topics: Animals; Arachidonic Acid; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Models, Chemical; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Sesquiterpenes; Sesquiterpenes, Guaiane; Thromboxanes

2006